MALVERN, PA — Ocugen, Inc. (Nasdaq: OCGN) launched a public offering of its common stock on July 31, 2024. The company also plans to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares sold in the offering. All shares will be sold by Ocugen.
Ocugen aims to use the proceeds for general corporate purposes, capital expenditures, working capital, and general administrative expenses.
Titan Partners Group, a division of American Capital Partners, is the sole book-running manager for the offering.
The offering is made under a shelf registration statement filed with the SEC on April 18, 2024, and effective as of May 1, 2024. The securities will be offered by means of a prospectus and prospectus supplement filed with the SEC.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.